Company Filing History:
Years Active: 2014-2015
Title: Katherine R Heemstra: Innovator in Pharmaceutical Science
Introduction
Katherine R Heemstra is a prominent inventor based in Chicago, IL, known for her significant contributions to pharmaceutical science. With a total of two patents to her name, she has made strides in developing innovative treatments for diseases characterized by the overexpression of anti-apoptotic Bcl-2 family proteins, such as cancer.
Latest Patents
Her latest patents include the ABT-263 capsule, which features a pharmaceutical capsule containing a liquid solution of ABT-263 or a pharmaceutically acceptable salt in a non-ethanolic carrier. This formulation is designed to treat diseases associated with the overexpression of Bcl-2 family proteins. Another notable patent is the stabilized lipid formulation of an apoptosis promoter, which comprises a Bcl-2 family protein inhibitory compound and a heavier-chalcogen antioxidant in a non-aqueous lipid carrier. This composition is suitable for oral administration and aims to provide effective treatment for similar diseases.
Career Highlights
Katherine is currently employed at AbbVie Inc., where she continues to advance her research and development efforts in the pharmaceutical field. Her work has been instrumental in creating formulations that enhance the efficacy of cancer treatments.
Collaborations
Throughout her career, Katherine has collaborated with notable colleagues, including Ping Tong and Deliang Zhou, contributing to a dynamic research environment that fosters innovation.
Conclusion
Katherine R Heemstra's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her patents reflect a commitment to improving treatment options for patients facing serious health challenges.